iShares U.S. Pharmaceuticals ETF (IHE) Dividend Yield, History & Forecast

iShares U.S. Pharmaceuticals ETF (IHE) is an exchange-traded fund (ETF) listed on the New York Stock Exchange Arca. It pays a current dividend yield of 1.71% ($1.75 per share annually (TTM)). The most recent ex-dividend date was September 15, 2026, with payment scheduled for September 18, 2026. market capitalization is approximately $1.14B. Review IHE dividend history on this scorecard, compare peers in the Compare Dividend Returns tool, or project income with the dividend calculator.

Loading quote...

IHE fund composition

IHE holds 54 positions, with 76.2% of assets in its ten largest. It charges an expense ratio of 0.37%, and manages $1.63B.

Top 10 holdings

HoldingWeight
JNJJOHNSON & JOHNSON22.82%
LLYELI LILLY20.48%
MRKMERCK & CO INC5.05%
BMYBRISTOL MYERS SQUIBB4.83%
RPRXROYALTY PHARMA PLC CLASS A4.59%
PFEPFIZER4.48%
VTRSVIATRIS4.21%
ZTSZOETIS INC CLASS A3.81%
JAZZJAZZ PHARMACEUTICALS PLC3.32%
ELANELANCO ANIMAL HEALTH2.59%

Sector allocation

Healthcare100.0%

Frequently Asked Questions about iShares U.S. Pharmaceuticals ETF (IHE)

What is iShares U.S. Pharmaceuticals ETF's dividend yield?
iShares U.S. Pharmaceuticals ETF (IHE) pays a current trailing twelve-month dividend yield of 1.71%, which works out to $1.75 per share annually based on the most recent payout schedule.
When does iShares U.S. Pharmaceuticals ETF pay its next dividend?
The most recent ex-dividend date was September 15, 2026. The next scheduled dividend payment date is September 18, 2026.
How many years has iShares U.S. Pharmaceuticals ETF increased its dividend?
iShares U.S. Pharmaceuticals ETF (IHE) has increased its dividend for 2 consecutive years.
Is iShares U.S. Pharmaceuticals ETF a Dividend Aristocrat?
No. Dividend Aristocrat status requires an S&P 500 listing and 25 or more consecutive years of dividend increases. iShares U.S. Pharmaceuticals ETF (IHE) currently has 2 years of consecutive increases.
What sector is iShares U.S. Pharmaceuticals ETF in?
iShares U.S. Pharmaceuticals ETF (IHE) operates in the Financial Services sector, specifically the Asset Management industry.